Total Payments
$61,891
2024 Payments
$2,528
Companies
58
Transactions
1,201
Medicare Patients
9,238
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$29,116 (47.0%)
Other$28,820 (46.6%)
Travel$2,250 (3.6%)
Consulting$692.00 (1.1%)
Education$602.67 (1.0%)
Gifts$410.35 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $29,116 | 1,153 | 47.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,820 | 15 | 46.6% |
| Travel and Lodging | $2,250 | 13 | 3.6% |
| Consulting Fee | $692.00 | 2 | 1.1% |
| Education | $602.67 | 17 | 1.0% |
| Gift | $410.35 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17,135 | 159 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $15,192 | 33 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $11,409 | 201 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,148 | 143 | $0 (2024) |
| PFIZER INC. | $1,358 | 61 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,155 | 37 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,045 | 36 | $0 (2023) |
| Philips Electronics North America Corporation | $1,032 | 58 | $0 (2022) |
| Genentech USA, Inc. | $1,027 | 69 | $0 (2024) |
| Amgen Inc. | $739.58 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,528 | 108 | AstraZeneca Pharmaceuticals LP ($929.81) |
| 2023 | $3,314 | 129 | AstraZeneca Pharmaceuticals LP ($723.59) |
| 2022 | $3,143 | 125 | AstraZeneca Pharmaceuticals LP ($556.70) |
| 2021 | $3,604 | 134 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,110) |
| 2020 | $4,109 | 150 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,040) |
| 2019 | $9,505 | 188 | Sunovion Pharmaceuticals Inc. ($4,956) |
| 2018 | $16,501 | 179 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,911) |
| 2017 | $19,187 | 188 | AstraZeneca Pharmaceuticals LP ($6,400) |
All Payment Transactions
1,201 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $27.26 | General |
| Category: Medical Device | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $32.24 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| Category: Sleep | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: Immunology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: ANTIBIOTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,552 | 6,179 | $891,105 | $501,232 |
| 2022 | 25 | 2,408 | 6,040 | $1.2M | $498,432 |
| 2021 | 27 | 2,318 | 4,804 | $952,636 | $400,922 |
| 2020 | 26 | 1,960 | 3,700 | $638,664 | $236,444 |
Total Patients
9,238
Total Services
20,723
Medicare Billing
$1.6M
Procedure Codes
110
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 125 | 1,221 | $181,060 | $118,261 | 65.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 142 | 1,486 | $167,378 | $101,516 | 60.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 312 | 787 | $162,967 | $85,601 | 52.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 53 | 154 | $69,318 | $30,300 | 43.7% |
| 94621 | Test for exercise-induced heart and lung stress | Office | 2023 | 168 | 205 | $58,475 | $29,194 | 49.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 115 | 344 | $38,566 | $24,854 | 64.4% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 74 | 96 | $20,249 | $13,420 | 66.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 193 | 230 | $27,212 | $12,072 | 44.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 77 | 96 | $15,629 | $10,428 | 66.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 202 | 244 | $21,322 | $9,525 | 44.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 60 | $18,856 | $9,494 | 50.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 49 | 57 | $14,752 | $9,412 | 63.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 190 | 228 | $25,034 | $7,824 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 73 | $10,672 | $5,655 | 53.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $7,030 | $5,370 | 76.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 66 | 69 | $7,150 | $5,198 | 72.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 43 | 50 | $7,394 | $3,804 | 51.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $6,001 | $3,177 | 52.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $5,346 | $2,995 | 56.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 24 | $3,991 | $2,525 | 63.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 67 | 70 | $3,750 | $2,457 | 65.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 125 | 227 | $4,116 | $1,907 | 46.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 15 | 16 | $3,327 | $1,609 | 48.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 156 | 178 | $4,110 | $835.16 | 20.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $1,100 | $771.98 | 70.2% |
About Dr. John Ashkar, M.D
Dr. John Ashkar, M.D is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073568184.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Ashkar, M.D has received a total of $61,891 in payments from pharmaceutical and medical device companies, with $2,528 received in 2024. These payments were reported across 1,201 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($29,116).
As a Medicare-enrolled provider, Ashkar has provided services to 9,238 Medicare beneficiaries, totaling 20,723 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Sleep Medicine
- Location Brooklyn, NY
- Active Since 05/24/2006
- Last Updated 01/14/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073568184
Products in Payments
- LONHALA MAGNAIR (Drug) $9,757
- BEVESPI AEROSPHERE (Drug) $7,542
- SPIRIVA RESPIMAT (Drug) $6,895
- UTIBRON (Drug) $5,409
- JARDIANCE (Drug) $4,457
- DUPIXENT (Biological) $1,703
- TRELEGY ELLIPTA (Drug) $1,269
- FASENRA (Biological) $1,149
- TEZSPIRE (Biological) $1,097
- ELIQUIS (Drug) $951.45
- Xolair (Biological) $817.94
- OFEV (Drug) $728.89
- SYMBICORT (Drug) $635.52
- NUCALA (Biological) $634.35
- BREZTRI (Drug) $615.79
- Arikayce (Drug) $565.94
- XOLAIR (Biological) $526.14
- (8874) inCourage (Device) $472.68
- OPSUMIT (Drug) $468.92
- SMARTVEST (Device) $458.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooklyn
Bruce Berger, M.d, M.D
Internal Medicine — Payments: $3.0M
Internal Medicine $3.0M
Dr. Jesi Ramone, Md, MD
Internal Medicine — Payments: $701,491
Internal Medicine $701,491
Dr. Ali El Atat, M.d, M.D
Internal Medicine — Payments: $426,309
Internal Medicine $426,309
Manish Parikh, Md, MD
Internal Medicine — Payments: $360,332
Internal Medicine $360,332
Dr. Samuel Uter, Md, MD
Internal Medicine — Payments: $238,375
Internal Medicine $238,375
Dr. Bharath Reddy, Md, MD
Internal Medicine — Payments: $159,733
Internal Medicine $159,733